Come up with a name for your new list and we'll add to it:
Tensha Therapeutics was acquired by
Roche Holding on January 11, 2016.
Tensha Therapeutics is a biotechnology company developing small molecule bromodomain inhibitors to regulate disease-linked gene transcription. Tensha noted that its lead preclinical program is intende…